Search Results - "Jindra, P. T."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Tolerance to MHC class II disparate allografts through genetic modification of bone marrow by Jindra, P T, Tripathi, S, Tian, C, Iacomini, J, Bagley, J

    Published in Gene therapy (01-05-2013)
    “…Induction of molecular chimerism through genetic modification of bone marrow is a powerful tool for the induction of tolerance. Here, we demonstrate for the…”
    Get full text
    Journal Article
  2. 2

    Phosphorylated S6 Ribosomal Protein: A Novel Biomarker of Antibody‐Mediated Rejection in Heart Allografts by Lepin, E. J., Zhang, Q., Zhang, X., Jindra, P. T., Hong, L. S., Ayele, P., Peralta, M. V. P., Gjertson, D. W., Kobashigawa, J. A., Wallace, W. D., Fishbein, M. C., Reed, E. F.

    Published in American journal of transplantation (01-07-2006)
    “…We tested the hypothesis that phosphorylation of S6 ribosomal protein (S6RP), a downstream target of the PI3K/Akt/mTOR pathway, is a biomarker of…”
    Get full text
    Journal Article
  3. 3

    Anti-HLA class I antibody–mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells by Jin, Yi-Ping, Fishbein, Michael C, Said, Jonathan W, Jindra, Peter T, Rajalingam, Raja, Rozengurt, Enrique, Reed, Elaine F

    Published in Human immunology (01-04-2004)
    “…Anti–human leukocyte antigen (HLA) antibodies (Ab) have long been implicated in the process of acute and chronic allograft rejection, yet their mechanism(s) of…”
    Get full text
    Journal Article
  4. 4

    Sequence Selective Recognition in the Minor Groove of dsDNA by Pyrrole, Imidazole-Substituted Bis-benzimidazole Conjugates by Reddy, Putta Mallikarjuna, Jindra, Peter T, Satz, Alexander L, Bruice, Thomas C

    Published in Journal of the American Chemical Society (02-07-2003)
    “…A series of pyrrole, imidazole-substituted bis-benzimidazole conjugates, Py-Py-Im-γ-biBenz, Py-Py-γ-biBenz, Py-Im-γ-biBenz, and Im-Py-γ-biBenz (1−4), were…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration by JINDRA, Peter T, XIAOHAI ZHANG, MULDER, Arend, CLAAS, Frans, VEALE, Jeffrey, JIN, Yi-Ping, REED, Elaine F

    Published in Transplantation (15-07-2006)
    “…Patients exhibiting a humoral immune response to the transplanted organ are at increased risk of antibody-mediated rejection and development of transplant…”
    Get full text
    Conference Proceeding Journal Article
  7. 7

    MHC class I and integrin ligation induce ERK activation via an mTORC2-dependent pathway by Jindra, Peter T., Jin, Yi-Ping, Jacamo, Rodrigo, Rozengurt, Enrique, Reed, Elaine F.

    “…The aim of this study was to characterize the interaction between mTOR and ERK in primary endothelial cells (EC) following MHC class I and integrin ligation…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection by JIN, Yi-Ping, JINDRA, Peter T, KE WEI GONG, LEPIN, Eric J, REED, Elaine F

    Published in Transplantation (15-02-2005)
    “…Transplant recipients exhibiting a humoral immune response to the allograft demonstrate lower graft survival and increased risk for the development of chronic…”
    Get full text
    Conference Proceeding Journal Article